Alterations in TLR5 sensing of the gut microbiome have been linked to the development of metabolic syndrome in TLR5−/− mice [114] and disrupted gut microbiota composition, hyperphagia, hyperlipidemia, hypertension, insulin resistance, and increased adiposity [115]. Here, TLR5 is linked to hypertensive disorder.